Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs-Reference-Cited by-同舟云学术

Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs

Published:2020-09 Issue:9 Volume:61 Page:1854-1868
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Patsalos Philip N.¹^ORCID,Szaflarski Jerzy P.²^ORCID,Gidal Barry³,VanLandingham Kevan⁴,Critchley David⁵,Morrison Gilmour⁵^ORCID

Affiliation:

1. Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK

2. Department of Neurology and University of Alabama at Birmingham Epilepsy Center University of Alabama at Birmingham Birmingham Alabama USA

3. School of Pharmacy University of Wisconsin–Madison Madison Wisconsin USA

4. Greenwich Biosciences, Inc. Carlsbad California USA

5. GW Research Ltd Cambridge UK

Funder

GW Research Ltd, Cambridge, UK

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16674

Reference51 articles.

1. Increased Risk of Death Among Children With Lennox-Gastaut Syndrome and Infantile Spasms

2. Lennox-Gastaut Syndrome (LGS): Development of conceptual models of health-related quality of life (HRQL) for caregivers and children

3. Mortality in Dravet syndrome

4. Treatment of Dravet Syndrome

5. Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A type of self-assembled and label-free DNA-modified electrochemical biosensors based on magnetic α-Fe2O3/Fe3O4 heterogeneous nanorods for ultra-sensitive detection of CYP2C19*3;Bioelectrochemistry;2024-12

2. Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program;Epilepsia Open;2024-08

3. Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex;Epilepsia Open;2024-07-15

4. Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain;European Journal of Pain;2024-07-09

5. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease;Current Issues in Molecular Biology;2024-05-06